Endurant Capital Management LP Avadel Pharmaceuticals PLC Transaction History

Endurant Capital Management LP

  • $0
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$7.25 - $11.75 $635,651 - $1.03 Million
-87,676 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$4.06 - $10.64 $355,964 - $932,872
87,676 New
87,676 $696,000
Q2 2018

Aug 14, 2018
SELL
$5.89 - $7.78 $328,073 - $433,346
-55,700 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$6.76 - $11.7 $376,532 - $651,690
55,700 New
55,700 $406,000

Others Institutions Holding AVDL

# of Institutions
8
Shares Held
1.07M
Call Options Held
0
Put Options Held
0
View Full List

About AVADEL PHARMACEUTICALS PLC

AVDL Quotes by TradingView
  • Ticker AVDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 60,581,300
  • Market Cap $661M
  • Description
  • Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...
More about AVDL
Track This Portfolio

Track Endurant Capital Management LP Portfolio

Follow Endurant Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email